Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
> >

Merck to halt study of mild to moderate Alzheimer's drug

Reuters Tuesday, 14 February 2017
(Reuters) - Merck & Co Inc said it would halt a late-stage trial of its drug in patients with mild to moderate Alzheimer's disease after an external panel pointed to a lack of effectiveness.
Share on
Share on
Post on 
Share by
Source: Wochit News - < > Embed

News video: Scientists Disappointed After New Alzheimer's Drug Failed

Scientists Disappointed After New Alzheimer's Drug Failed 00:35

Researchers found that the new promising Alzheimer’s drug verubecestat did not work. Dr. Roger Perlmutter, president of Merck Research Laboratories, stated, “While we are disappointed that a benefit was not observed in this study, our work continues [to study the impact of] verubecestat in people...

You Might Like

Other recent news in Health

World TB Day-DOTS और TUBERCULOSIS को संभालने के 5 बेसिक उपाय।MAHARASHTRA Doctor’s Strike: We need to act so we don’t see more such strikes in future?
Last-minutes changes to the GOP HEALTH CARE billTrump: Pass Health Care Friday, or OBAMACARE Stays
House rules panel clears Trump-backed Obamacare REPEAL BILL for debateRisky House HEALTHCARE VOTE to test Trump's negotiating skills
Report: STATE DEPARTMENT to Approve Keystone Pipeline FridayGrowing Disconnect with China Seen Ahead of HONG KONG Election
LONDON AttackSOUTH KOREA: North Ready for Nuclear Test 


Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+